Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06568016 · ClinicalTrials.gov registry record · NA

A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers

A NA study of Colorectal Carcinoma, sponsored by Jonsson Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
1,500
Enrollment target
2
Study locations

NCT06568016: Recruiting NA study of Colorectal Carcinoma, sponsored by Jonsson Comprehensive Cancer Center.

NCT06568016 is a NA study of Colorectal Carcinoma that is actively recruiting participants, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 1,500 participants, above the 1,068-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (40% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06568016, a NA study of Colorectal Carcinoma, is actively recruiting participants, sponsored by Jonsson Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
1,500 participants
Enrollment target
2
Study locations

Study Summary

This clinical trial evaluates a clinic-wide intervention called Primary Care-Gastrointestinal (GI) Connect for improving follow-up colonoscopy rates in patients at a Federally Qualified Health Center (FQHC) who have an abnormal fecal immunochemical test (FIT) result. Colorectal cancer screening reduces colorectal cancer incidence and mortality but is underutilized.The most accessible, feasible, and common colorectal cancer screening modality for average-risk individuals in low resource settings such as FQHCs is the stool-based FIT. However, the benefit of FIT screening on colorectal cancer risk is realized only if individuals with abnormal FIT results undergo timely follow-up colonoscopy. Follow-up colonoscopy rates are low and there are many barriers to follow-up colonoscopy in safety net settings such as FQHCs. Effective interventions that are multi-component and improve care coordination are needed to improve abnormal FIT follow-up rates in FQHCs. The Primary Care-GI Connect intervention includes components that enhance care coordination, standardize the referral process, and engage both primary care and specialist physicians. This clinic-wide intervention may improve rates of follow-up colonoscopy after abnormal FIT results in patients seen at FQHCs.

Primary Outcome

Evaluated in patients with an abnormal fecal immunochemical test (FIT) result using electronic health record data. Will use a difference-in-differences approach, assessing whether change in completion rates from baseline to the implementation period differs between the intervention and usual care conditions, thus accounting for potential differences among clinics pre-implementation. Will fit a mixed effects logistic regression model with a dependent variable of patient-level colonoscopy completi

Conditions Studied

Interventions

  • OTHER Best Practice
  • OTHER Educational Intervention
  • OTHER Communication Intervention
  • OTHER Coordination

Study Locations (2)

California

  • University of California at Los Angeles - Los Angeles
  • UCLA / Jonsson Comprehensive Cancer Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2025-04-22
Est. Completion 2029-08-31
Phase NA
Jonsson Comprehensive Cancer Center

321 total trials

What NCT06568016 shows while recruiting

NCT06568016 is an interventional study that assigns participants to a tested intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,068-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (40% higher).

The record links to 1 condition, with Colorectal Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Best Practice is the first listed.

NCT06568016 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06568016 about?

NCT06568016 is a clinical study titled "A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers". This clinical trial evaluates a clinic-wide intervention called Primary Care-Gastrointestinal (GI) Connect for improving follow-up colonoscopy rates in patients at a Federally Qualified Health Center (FQHC) who have an abnormal fecal immunochemical test (FIT) result. Colorectal cancer screening redu...

What is the current status of trial NCT06568016?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,500 participants. The study started on 2025-04-22. Estimated completion is 2029-08-31.

What conditions does trial NCT06568016 study?

This clinical trial studies the following conditions: Colorectal Carcinoma.

What interventions are being tested in trial NCT06568016?

The interventions under investigation include: Best Practice (OTHER), Educational Intervention (OTHER), Communication Intervention (OTHER), Coordination (OTHER).

Who is sponsoring clinical trial NCT06568016?

This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06568016 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06568016's enrollment target sits among peer trials

1,500 8th of 53 higher than 46 of 53 other Colorectal Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • NCT02071134 · 1,500 participants

    Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06568016, the US trial registry maintained by the National Library of Medicine. NCT06568016 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.